Dr. Stefano Persiani is within the Internal & External Innovation, Director of Translational Sciences and Pharmacokinetics at Rottapharm Biotech, Italy since the year 2000. Dr. Persiani received his Ph.D. in Pharmacy from the University of Milan, in Italy and completed his Post-Doctoral fellowship in the Department of Pathology of the University of Pittsburgh, School of Medicine, Pittsburgh, Pennsylvania, USA. After his Post-Doctoral Fellowship, Dr. Persiani served as Research Associate in the Department of Pharmaceutics of the University of Southern California, School of Pharmacy in Los Angeles, California, USA. After these academic experiences, he entered the pharmaceutical industry in Farmitalia Carlo Erba, Pharmacia, and Upjohn, and Zambon Group and also as the Scientific Director in clinical pharmacology CROs.
Dr. Persiani experience consists in translational approaches for drug discovery and development for successful drug discovery and development. Regulatory pre-clinical development package and early clinical development. Dr. Persiani is a member of various international scientific societies and serves on the review board of numerous professional journals. Dr. Persiani acts as an external expert evaluator for the European Commission on the 7th Framework Program, Maria Sklodowska-Curie Individual Fellowships, HORIZON 2020, and Innovative Medicine Initiative. Dr. Persiani is also an expert evaluator for La Caixa Foundation and for the Slovak Republic’s Research Agency. Dr. Persiani is a faculty of the University of Milan Bicocca, School of Medicine and a trainer at Pharmaceutical Training International, Traininng.com, GRC educators, and Compliance IQ where he provides lectures and training courses to pharmaceutical companies.